Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study

Dall, 2014, The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes, Diabetes Care, 37, 3172, 10.2337/dc14-1036

1999, The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes, Diabetes Care, 22, 623, 10.2337/diacare.22.4.623

2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512

Pan, 1997, Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801

Whittemore, 2011, A systematic review of the translational research on the Diabetes Prevention Program, Transl Behav Med, 1, 460, 10.1007/s13142-011-0062-y

2009, 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study, Lancet, 14, 1677

2002, The diabetes prevention program (DPP): description of lifestyle intervention, Diabetes Care, 25, 2165, 10.2337/diacare.25.12.2165

2003, Effect of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program, Diabetes Care, 26, 977, 10.2337/diacare.26.4.977

Venditti, 2008, First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes, Int J Obes, 32, 1537, 10.1038/ijo.2008.134

Levey, 2009, Chronic Kidney Disease Epidemiology Collaboration: a new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

1991, Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12, Ophthalmology, 83, 823

Olaleye, 2001, Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic, Diabetes Res Clin Pract, 54, 115, 10.1016/S0168-8227(01)00278-9

Lachin, 2009

Zeger, 1986, Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121, 10.2307/2531248

Lefkopoulou, 1993, Global tests for multiple binary outcomes, Biometrics, 49, 975, 10.2307/2532240

Pan, 2001, Sample size and power calculations with correlated binary data, Control Clin Trials, 22, 211, 10.1016/S0197-2456(01)00131-3

Diggle, 1994

Hamman, 2015, Factors affecting the decline in incidence of diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS), Diabetes, 64, 989, 10.2337/db14-0333

2013, Economic costs of diabetes in the US in 2012, Diabetes Care, 36, 1033, 10.2337/dc12-2625

Harjutsalo, 2011, Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes, Diabetologia, 54, 1992, 10.1007/s00125-011-2144-2

2014, Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomized clinical trial, Lancet Diabetes Endocrinol, 2, 801, 10.1016/S2213-8587(14)70156-1

Nelson, 1989, Albuminuria in type 2 (non-insulin-dependent) diabetes and impaired glucose tolerance in Pima Indians, Diabetologia, 32, 870, 10.1007/BF00297452

Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405

Li, 2014, Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing diabetes prevention study: a 23-year follow-up study, Lancet Diabetes Endocrinol, 2, 474, 10.1016/S2213-8587(14)70057-9

2005, Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors, Diabetes Care, 28, 888, 10.2337/diacare.28.4.888

2005, Metformin and intensive lifestyle intervention on the prevention of the metabolic syndrome, Ann Intern Med, 142, 611, 10.7326/0003-4819-142-8-200504190-00009

Brown, 2006, Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program, Diabetes Care, 29, 385, 10.2337/diacare.29.02.06.dc05-1781

Florez, 2012, Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial, J Gen Intern Med, 27, 1594, 10.1007/s11606-012-2122-5

2012, The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention, Diabetes Care, 35, 723, 10.2337/dc11-1468

Geiss, 2014, Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012, JAMA, 312, 1218, 10.1001/jama.2014.11494